| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD-2281 | FIMM | pan-cancer | AAC | 0.39 | 0.01 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.02 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | 0.076 | 0.02 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | -0.078 | 0.02 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.079 | 0.02 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.14 | 0.02 |
| mRNA | GDC-0449 | FIMM | pan-cancer | AAC | 0.39 | 0.02 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.072 | 0.02 |
| mRNA | serdemetan:SCH-529074 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.08 | 0.02 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | 0.12 | 0.02 |